Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

Dry January Can Boost Weed Sales: This Week in Cannabis Investing

Reports indicate the annual trend of giving up alcohol in January can help increase recreational cannabis sales.

Kiplinger

Terry Dubrow endorses Ozempic for weight loss, dismisses Tylenol dangers

Terry Dubrow, star of Botched, advocates for the use of Ozempic for weight loss, claiming it is safer than Tylenol and effective in treating obesity.

Top News

3 Lucrative Pharma Stocks for Portfolio Success

The pharmaceutical industry holds immense promise due to the rapidly aging population, growing healthcare needs, breakthroughs in new drugs and therapies, and the rise in chronic diseases. Therefore, it could be wise to add fundamentally strong pharma stocks Supernus Pharmaceuticals (SUPN), Eton Pharmaceuticals (ETON), and Viatris (VTRS) to one’s portfolio.…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

FTC probe drugmakers’ patent thickets

The Federal Trade Commission has challenged more than 100 patents drugmakers listed in the FDA’s “Orange Book"

Salon

Restricting abortion drug access

The Supreme Court will soon decide the fate of access for mifepristone. The fallout of a ban would be tremendous

Salon

Up First briefing: Houses passes child tax credit bill; EU agrees on Ukraine aid

The House approved a bipartisan bill that would expand the child tax credit. As tensions between Zelenskyy and his military chief rise, the EU agrees to more than $50 billion in aid for Ukraine.

WEKU

Biogen Pulls Controversial Alzheimer's Drug Aduhelm

A controversial Alzheimer's drug that was trumpeted as the first to ever treat the cognitive decline associated with the devastating brain disorder has been pulled from the market, its maker Biogen announced Wednesday.

International Business Times

Read news from The Economist, FT, and more,
with one subscription

Top 4 Pharma Stocks on the Rise for Potential Gains

Growing medical needs, surging demand for precision medicine, favorable regulatory climate, and rapid digital transformation would create promising growth opportunities for pharma companies. Hence, it could be wise to invest in top pharma stocks Johnson & Johnson (JNJ), Spero Therapeutics (SPRO), Ipsen (IPSEY), and Procaps Group (PROC) for solid gains.…

StockNews.com

Philips to stop selling apnea machines

The breathing machine manufacturer has faced relentless criticism over its handling of the 2021 recall of millions

Salon

Elon Musk's Neuralink Company Implants Brain Chip In A Human For The First Time

Neuralink received FDA permission for its first-in-human clinical trial in May 2023.

International Business Times UK

Neuralink's Quantum Leap? Elon Musk Claims Brain Implant Breakthrough

Neuralink, Elon Musk's pioneering tech startup, claimed a major milestone with a successful brain implant in a human patient.

International Business Times

Elon Musk's X prepares for Congressional testimony with new CEO

Discover how Elon Musk's company, X, navigates the regulatory landscape, as its new CEO, Linda Yaccarino, testifies in front of Congress.

Top News

What is Neuralink and how does it work? Elon Musk's firm says first brain-chip patient now plays online chess

A video has been shared on X showing just what the brain chip can do, as well as revealing the identity of the patient for the first time

Evening Standard

The ketamine economy: New mental health clinics are a 'Wild West' with few rules

Ketamine, approved as an anesthetic in 1970, is emerging as a major alternative mental health treatment. But more than 500 clinics have popped up with little regulation, and treatment varies widely.

WEKU

Get all your
news in one place.

100's of premium titles.
One news app.

International Business Times

First Human To Receive Neuralink Brain Chip Implant Recovering Well: Elon Musk

Around four months since Neuralink announced its human trials, the brain chip startup founded by Elon Musk has implanted its brain chip on the first human, the tech mogul announced Monday.

Kiplinger

Breakthroughs in Alzheimer’s Research Give Cause for Optimism

Advances in Alzheimer’s research raise hopes of preventing and someday curing the senior plague.

International Business Times

Philips Stops Selling Sleep Devices In US Amid Recall Woes

Under-fire Dutch medical device maker Philips said Monday it would halt new sales of sleep machines in the United States after a series of recalls that continued to weigh on results.

TechRadar

Wainlux K8 10W Laser Engraving Machine review

A laser engraver ideal for small-scale, diverse projects in various settings.

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - US

‘I don’t see how it ends’: expert sounds alarm on new wave of US opioids crisis

Dr Art Van Zee set out in the early 2000s to tell anyone who would listen how a powerful opioid was destroying lives. Two decades later, he’s still in disbelief

The Guardian - US

Biden hopes abortion will keep him in the White House. But has he done enough to protect rights?

The president has made big promises and held the line against legal challenges, but activists say he could be doing more

Medical Daily

Robitussin Cough Syrups Recalled Due To Microbial Contamination

The distributors have been notified and provided with instructions for the return of all recalled products.

Android Central

Here's how the Pixel 8 Pro's FDA-cleared body temperature sensor works

Google recently added support for taking your body's temperature with the Pixel 8 Pro, and this is how the feature works.

StockNews.com

3 Lucrative Biotech Stock Buys for Success

The development of orphan medications, innovative biotech equipment, personalized medicine, and strong government support are all contributing to the biotech industry's upward trajectory. Thus, lucrative biotech stocks Vertex Pharmaceuticals (VRTX), Innoviva (INVA), and Organogenesis Holdings (ORGO) could be ideal additions to your portfolio right now. Read more….

Top News

Senator Chuck Schumer calls for federal shutdown on Zen nicotine pouches

This news report highlights Senator Chuck Schumer's call for a federal shutdown on Zen nicotine pouches due to concerns over its impact on young people.

StockNews.com

Will These 3 Biotech Stocks Make Gains in 2024?

In the swiftly progressing arena of biotechnology, technological advancements, increasing merger and acquisition maneuvers, and developing product pipelines are driving significant expansion in this sector. The sector's strong potential is further reinforced by a steady demand, ensuring its sustenance. Given this backdrop, let’s analyze whether or not biotech stocks Illumina…

1 … 109 110 111 112

People

Dipanjan BanchurSince

Sristi Suman JayaswalThe

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.